Loading markets…

BioMarin Pharmaceutical Inc. (BMRN) forecast

BioMarin Pharmaceutical Inc. (BMRN) forecast: price $56.27, trailing P/E 145.29, forward P/E 15.82. How to read the street's path.

$56.27Price
$10.89BMarket cap
145.29P/E ?
15.82Forward P/E ?
0.00%Dividend yield ?

The live BMRN price is $56.27. Trailing P/E is 145.29 and forward P/E is 15.82. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the BMRN forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full BMRN quote · Dividends · Price prediction · Academy

Questions

What is BMRN's forward P/E?

The latest forward P/E on Stocklytics is 15.82, against a trailing P/E of 145.29 and a price of $56.27.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.